Bear Stearns hires John Boris as pharmaceutical analyst

By Jennifer Chiou

New York, June 24 - Bear, Stearns & Co. Inc. said it hired John Boris as an equity research analyst to cover the pharmaceutical sector.

Boris, a managing director who has 20 years of experience in pharmaceuticals, replaces long-time analysts Joseph Riccardo and Scott Shevick, who are joining Bear Stearns Asset Management, Inc. as portfolio managers.

Prior to Bear Stearns, Boris worked in the equity division of Harris Nesbitt, owned by the Bank of Montreal, and worked also a registered pharmacist.

"John brings with him a combination of real industry experience and the ability to conduct in-depth analysis, which our clients will find extremely valuable," said Kay Booth, director of global equity research, in a news release.

Riccardo, at Bear Stearns since 1979, has covered the pharmaceutical industry for more than 20 years, most recently as senior healthcare analyst.

Shevick has been with Bear Stearns since 1992 while focusing on the major, specialty and generic drug industries.

New York-based Bear Stearns is an investment banking, securities trading and brokerage firm.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.